Strategic Overview

LumiraDx is a diagnostics company developing point-of-care molecular and biomarker tests for infectious diseases including TB.

Innovation Portfolio

LumiraDx CRP
Category: SCREENING Stage: Commercial

Microfluidic fluorescence immunoassay platform for rapid quantitative CRP testing at point-of-care. Supports infection triage and TB screening workflows.

Biomarker Blood

Key Milestones

LumiraDx CRP biomarker test
LumiraDx TB POC molecular test in development
Rapid turnaround times (4-20 minutes)
Global distribution network